These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2788743)

  • 21. Synthesis and biological evaluation of some novel cyclic-imides as hypoglycaemic, anti-hyperlipidemic agents.
    Abdel-Aziz AA; El-Azab AS; Attia SM; Al-Obaid AM; Al-Omar MA; El-Subbagh HI
    Eur J Med Chem; 2011 Sep; 46(9):4324-9. PubMed ID: 21783284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on antihyperlipidemic agents. III. Synthesis and biological activities of 2-chloro-3-arylpropionic acids containing a quarternary carbon atom.
    Kawamatsu Y; Asakawa H; Saraie T; Mizuno K; Imamiya E; Nishikawa K; Hamuro Y
    Arzneimittelforschung; 1980; 30(5):751-8. PubMed ID: 7190414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the chemical reactivities and antineoplastic activities of alpha,beta-, alpha,beta'-, beta,beta'-, and alpha,alpha'-bis[[[(2-propylamino)carbonyl]oxy]methyl]-substituted pyrroles.
    Anderson WK; Heider AR
    J Med Chem; 1986 Nov; 29(11):2392-5. PubMed ID: 3783597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and hypolipidemic activity of diesters of arylnaphthalene lignan and their heteroaromatic analogs.
    Kuroda T; Kondo K; Iwasaki T; Ohtani A; Takashima K
    Chem Pharm Bull (Tokyo); 1997 Apr; 45(4):678-84. PubMed ID: 9145504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early effects on mitochondrial and peroxisomal beta-oxidation by the hypolipidemic 3-thia-fatty acids in rat livers.
    Asiedu DK; Skorve J; Willumsen N; Demoz A; Berge RK
    Biochim Biophys Acta; 1993 Feb; 1166(1):73-6. PubMed ID: 8431494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypolipidemic activity of phthalimide derivatives V: Reduced and hydrolytic products of simple cyclic imides.
    Chapman JM; Wyrick SD; Josée Voorstad P; Maguire JH; Cocolas GH; Hall IH
    J Pharm Sci; 1984 Oct; 73(10):1482-4. PubMed ID: 6502502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flavone-based novel antidiabetic and antidyslipidemic agents.
    Verma AK; Singh H; Satyanarayana M; Srivastava SP; Tiwari P; Singh AB; Dwivedi AK; Singh SK; Srivastava M; Nath C; Raghubir R; Srivastava AK; Pratap R
    J Med Chem; 2012 May; 55(10):4551-67. PubMed ID: 22524508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term effects of hypolipidemic peroxisome proliferator administration on hepatic hydrogen peroxide metabolism in rats.
    Tamura H; Iida T; Watanabe T; Suga T
    Carcinogenesis; 1990 Mar; 11(3):445-50. PubMed ID: 2311188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel euglycemic and hypolipidemic agents. 4. Pyridyl- and quinolinyl-containing thiazolidinediones.
    Lohray BB; Bhushan V; Reddy AS; Rao PB; Reddy NJ; Harikishore P; Haritha N; Vikramadityan RK; Chakrabarti R; Rajagopalan R; Katneni K
    J Med Chem; 1999 Jul; 42(14):2569-81. PubMed ID: 10411477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of dietary treatment with 11 dicarboxylic acids, diethylcarboxylic esters and fatty acids on peroxisomal fatty acid beta-oxidation, epoxide hydrolases and lauric acid omega-hydroxylation in mouse liver.
    Lundgren B; Andersson K; DePierre JW
    Biochem Pharmacol; 1992 Feb; 43(4):785-92. PubMed ID: 1540233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate.
    Peters JM; Zhou YC; Ram PA; Lee SS; Gonzalez FJ; Waxman DJ
    Mol Pharmacol; 1996 Jul; 50(1):67-74. PubMed ID: 8700121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic peroxisome proliferation: induction by two novel compounds structurally unrelated to clofibrate.
    Reddy JK; Krishnakantha TP
    Science; 1975 Nov; 190(4216):787-9. PubMed ID: 1198095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, hypoglycemic and hypolipidemic activities of novel thiazolidinedione derivatives containing thiazole/triazole/oxadiazole ring.
    Mohammed Iqbal AK; Khan AY; Kalashetti MB; Belavagi NS; Gong YD; Khazi IA
    Eur J Med Chem; 2012 Jul; 53():308-15. PubMed ID: 22575535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis and in vivo screening of some novel quinazoline analogs as anti-hyperlipidemic and hypoglycemic agents.
    Mokale SN; Palkar AD; Dube PN; Sakle NS; Miniyar PB
    Bioorg Med Chem Lett; 2016 Jan; 26(2):272-276. PubMed ID: 26707395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of hepatocyte nuclear factor-4alpha by acyl-CoA thioesters of hypolipidemic peroxisome proliferators.
    Hertz R; Sheena V; Kalderon B; Berman I; Bar-Tana J
    Biochem Pharmacol; 2001 May; 61(9):1057-62. PubMed ID: 11301038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The hypolipidemic peroxisome-proliferating drug, bis(carboxymethylthio)-1.10 decane, a dicarboxylic metabolite of tiadenol, is activated to an acylcoenzyme A thioester.
    Aarsland A; Berge RK; Bremer J; Aarsaether N
    Biochim Biophys Acta; 1990 Feb; 1033(2):176-83. PubMed ID: 2306462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of antilipolytic agents on rat liver peroxisomes and peroxisomal oxidative activities.
    Locci Cubeddu T; Masiello P; Pollera M; Bergamini E
    Biochim Biophys Acta; 1985 Mar; 839(1):96-104. PubMed ID: 3978124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacomodulation of 7-(2-methylene-butyryl)-2,3-dihydrobenzoxazin-[1,4]-3-one structure and normolipemic activity.
    Moussavi Z; Depreux P; Lesieur D; Cotelle N; Sauzieres J; Plancke MO; Fruchart JC
    Farmaco; 1991 Feb; 46(2):339-55. PubMed ID: 1859587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between the cellular level of long-chain acyl-CoA, peroxisomal beta-oxidation, and palmitoyl-CoA hydrolase activity in rat liver. Are the two enzyme systems regulated by a substrate-induced mechanism?
    Berge RK; Aarsland A
    Biochim Biophys Acta; 1985 Nov; 837(2):141-51. PubMed ID: 2864957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypolipidemic 2-[4-(1,1-dimethylethyl)phenyl]-4H-3,1-benzoxazin-4-ones. Structure-activity relationships of a novel series of high-density lipoprotein elevators.
    Fenton G; Newton CG; Wyman BM; Bagge P; Dron DI; Riddell D; Jones GD
    J Med Chem; 1989 Jan; 32(1):265-72. PubMed ID: 2909740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.